Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

PharmaNutrics Adds Two Immunity Supplements to Expanding U.S. Product Line

Unique Immunomix formula addresses growing consumer interest in immune defense


News provided by

PharmaNutrics USA

Mar 10, 2022, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Vitamin D3 and Immunomix from PharmaNutrics
Vitamin D3 and Immunomix from PharmaNutrics

WOODSTOCK, Ill., March 10, 2022 /PRNewswire-PRWeb/ -- With the world living under the cloud of the COVID-19 pandemic the past two years, there has been increased focus on immune health. In response to consumer interest in this area, today PharmaNutrics announced the addition of two new supplements to its growing U.S. product line, Immunomix and Vitamin D3, both which provide immune system support.

"We continue to expand our product offerings to address our customers' needs, and the pandemic has resulted in increased interest in people wanting to build their body's defenses," said Paul Vosters, PharmaNutrics Chairman of the Board. "Today we are introducing Immunomix and Vitamin D3 in response to the growing demand for supplements that can help consumers get the nutrients they need to stay healthy."

“We continue to expand our product offerings to address our customers’ needs, and the pandemic has resulted in increased interest in people wanting to build their body’s defenses.”

Post this

Immunomix offers ongoing immune support
Immunomix, a product unique to PharmaNutrics, can be used for long-term health and support of the body's natural defenses against viruses and other illnesses. This unique blend of micronutrients combines vitamins C and D3 with copper, selenium, zinc, and manganese, as well as quercetin, beta-glucan, and lactoferrin, which work synergistically to support immune health.

When taken consistently, this formulation is designed to promote antioxidant activity and white blood cell activity for healthy aging and lower risk of health issues due to viral illnesses.

"A nutritious diet is an important part of immune health," said Ine Ravelingien, PharmaNutrics' Vice President of Product Management and Innovation. "Immunomix was developed to supplement deficiencies and strengthen the immune response to support the body's ability to defend against colds, flus, and other viruses. Immunomix is meant to be taken daily to protect the body from getting sick."

Vitamin D3 drops support immune and musculoskeletal health
Vitamin D3 is best known for promoting strong bones and healthy teeth, and it's also a powerful tool for immune health. It is believed to help control inflammation and boost the production of pathogen-fighting proteins. Many people are deficient in vitamin D3 due to their age, lifestyle, and the climate in which they live, and may overcome vitamin D3 deficiency with dietary supplements. PharmaNutrics' Vitamin D3 is available in drop format for easier ingestion and faster absorbency.

"I would recommend taking vitamin D3 if you're at risk for vitamin D deficiency or if it has been recommended by your doctor. Vitamin D has many benefits throughout the body, including immune support and musculoskeletal health," said Ravelingien.

GlucanPlus also supports immune health with beta-glucan and zinc
Immunomix and Vitamin D3 add to PharmaNutrics' growing line of immune defense supplements, which also includes GlucanPlus. GlucanPlus uses a high dose of beta-glucan with additional zinc to help the body fight off infection. Whereas Immunomix must be taken consistently over time to support the body's defenses against illness, GlucanPlus can be taken preventatively, or once symptoms of infection set in.

New supplements build on 2021 launch
PharmaNutrics launched in the U.S. in December 2021 with five products, including CurcumixPlus for joint and muscle pain related to inflammation; EnergixPlus, to fight fatigue; SerotomixPlus for chronic stress and worry; GlucanPlus for immune support; and Gaba 600 for short-term stress support. As always, customers should consult with their medical provider when adding supplements to their diet.

About PharmaNutrics USA
PharmaNutrics USA is a wellness company that believes it's never too late to get healthy and stay healthy. We are committed to developing safe, beneficial dietary supplements and health guidance that help our customers feel balanced, energetic, and calm at any stage of life. From raw materials to the finished product, our goal is to maximize the purity, safety, and benefits of each product. We focus on quality ingredients of high purity and potency, as well as unique formulas that target a variety of health and wellness needs. Visit https://www.pharmanutrics.com/ for more information.

Media Contact

Ronda Duncan, Spring Marketing Group, 8472549782, [email protected]

SOURCE PharmaNutrics USA

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.